Cytologic and Immunophenotypic Features of CD34+ Stem Cells in Body Cavity Fluids

被引:1
|
作者
Kataoka, Hideo [2 ]
Okabe, Hidetoshi [1 ]
Amano, Shigeru
Yamada, Eiji [2 ]
Ishida, Mitsuaki [1 ]
Kushima, Ryoji
Kobayashi, Tadao K. [3 ]
机构
[1] Shiga Univ Med Sci, Dept Clin Lab, Ohtu, Shiga 5202192, Japan
[2] Shiga Univ Med Sci, Dept Clin Lab, Hikone Municipal Hosp, Ohtu, Shiga 5202192, Japan
[3] Imperial Gift Fdn Fdn, Dept Pathol, Saiseikai Shiga Hosp, Osaka, Shiga, Japan
关键词
Body cavity fluid; CD34; Immunocytochemistry; Stem cells; GROWTH-FACTOR RECEPTOR; MALIGNANT MESOTHELIOMA; BONE-MARROW; BLOOD; ANTIGEN; DIFFERENTIATION; EXPRESSION; D2-40; NICHE;
D O I
10.1159/000337452
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Objectives: The possibility of leakage of CD34+ bone marrow stem cells from the peripheral blood into the coelomic cavity and the capability of coelomic fluid factors to induce their non-hematogenous differentiation were examined by immunocytochemistry (ICC). Study Design: Body cavity fluid smears from 12 and 18 patients with and without cancer, respectively, were processed for double immunoperoxidase or double fluorescent ICC methods using antibodies against CD34, CD14, CD16, CD68, AE1/AE3, epidermal growth factor receptor (EGFR), D2-40, and CA125. Results: Heavily irritated exudative fluid from 6 patients with or without cancer contained a few small round cells positive for CD34. Some of them co-expressed myeloid or monocytic markers such as CD14, CD68 or CD16. Some of the CD34+ cells also co-expressed AE1/AE3 or EGFR. In addition, D2-40 and CA125 were also demonstrated though the expression of the latter was quite sporadic. Conclusion:These findings support the concept that CD34+ stem cells can be released into irritated body cavity fluid and the possibility of subsequent differentiation to a non-hematogenous lineage under the influence of local humoral factors, in agreement with our previous in vitro experiments. The possibility of such a phenomenon should be kept in mind when body cavity fluid specimens are analyzed by ICC for diagnostic purposes. Copyright (c) 2012 S. Karger AG, Basel
引用
收藏
页码:401 / 407
页数:7
相关论文
共 50 条
  • [1] Cytologic and Immunophenotypic Features of Malignant Cells in Pediatric Body Fluids
    Ahmed, Atif A.
    Andraws, Nevene
    Almutairi, Ahmed M.
    Saied, Hesham M.
    Elbagir-Mohamed, Asim M.
    ACTA CYTOLOGICA, 2015, 59 (04) : 332 - 338
  • [2] Human CD34+ Hematopoietic Stem Cell-Engrafted NSG Mice: Morphological and Immunophenotypic Features
    Bluemich, Sandra
    Zdimerova, Hana
    Muenz, Christian
    Kipar, Anja
    Pellegrini, Giovanni
    VETERINARY PATHOLOGY, 2021, 58 (01) : 161 - 180
  • [3] Hematopoietic stem cells can be CD34+ or CD34-
    Donnelly, DS
    Krause, DS
    LEUKEMIA & LYMPHOMA, 2001, 40 (3-4) : 221 - +
  • [4] Clinical, cytologic, and immunohistochemical features of sarcomas involving body cavity fluids
    Chen, Athena L.
    Janko, Elizabeth
    Pitman, Martha B.
    Chebib, Ivan
    CANCER CYTOPATHOLOGY, 2019, 127 (12) : 778 - 784
  • [5] THE CYTOLOGIC EXAMINATION OF BODY CAVITY FLUIDS
    OBRIEN, PJ
    LUMSDEN, JH
    SEMINARS IN VETERINARY MEDICINE AND SURGERY-SMALL ANIMAL, 1988, 3 (02): : 140 - 156
  • [6] Immunophenotypic peculiarities of mobilized stem (CD34+) cells in blood from patients with severe spinal cord injury
    Tupitsyn, N. N.
    Yaryghin, V. N.
    Bryukhovetskiy, A. S.
    Grivtsova, L. Yu.
    Mentkevich, G. L.
    Dolgopolov, I. S.
    Zaitsev, A. Yu.
    Davydov, M. I.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2006, 20 (1-2): : 36 - 40
  • [7] Immunophenotypic characteristics of PB-mobilised CD34+ hematopoietic progenitor cells
    Menéndez, P
    del Cañizo, MC
    Orfao, A
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2001, 15 (01): : 53 - 61
  • [8] Immunophenotypic characteristics of cord blood and clonogenicity of CD34+ enriched cells.
    Kalmanti, M
    Dimitriou, H
    Matsouka, H
    Lydaki, E
    Bolonaki, I
    Stiakaki, E
    BONE MARROW TRANSPLANTATION, 1998, 21 : S25 - S25
  • [9] CD34+ cells reprogrammed to act as embryonic stem cells
    不详
    EXPERT REVIEW OF HEMATOLOGY, 2009, 2 (03) : 224 - 224
  • [10] CD34+ stem cells in chronic myeloproliferative disorders
    Thiele, J
    Kvasnicka, HM
    HISTOLOGY AND HISTOPATHOLOGY, 2002, 17 (02) : 507 - 521